Sirios Capital Management L P Biogen Inc. Transaction History

Sirios Capital Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.91 Million - $2.63 Million	9,809 New	9,809 $2.62 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1.05 Million - $1.33 Million	-3,760 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $398,293 - $520,857	1,357 Added 56.47%	3,760 $1.33 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $354,347 - $422,308	-1,376 Reduced 36.41%	2,403 $697,000
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $983,031 - $1.39 Million	3,779 New	3,779 $1.04 Million

1,006

129M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sirios Capital Management L P, based on Form 13F filings with the SEC.

Stay updated on Sirios Capital Management L P with notifications on news.